Research reading
Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale demand and the United States (USA) to Zambia (ZMB) lane
Zambia (ZMB) reported $1.6K of blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale imports in 2024. United States (USA) accounted for 3.8% of the observed market and reported $60.3 in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +58% buyer growth and +76.2% exporter growth. The page separates reported values from projections and indicators.
